Ibaraki, Japan

Toshihide Shikanai

This inventor holds 1 USPTO granted patent. Top assignees: Glycobiomarker Leading Innovation Co., Ltd., National Center for Global Health and Medicine, National Institute of Advanced Industrial Science and Technology. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshihide Shikanai. Retrieved from https://idiyas.com/inventor/toshihide-shikanai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Toshihide Shikanai in Hepatic Disease Detection.

Introduction

Toshihide Shikanai is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of hepatic diseases. His work focuses on developing innovative glycan markers that can indicate the state of liver diseases, including hepatocarcinoma.

Latest Patents

Toshihide Shikanai holds a patent for "Glycan markers as measure of disease state of hepatic diseases." This invention aims to develop glycan markers capable of detecting hepatic diseases. Specifically, it addresses the need for markers that can distinguish between different hepatic disease states, especially in the progression of hepatocarcinoma. The invention identifies glycopeptides and glycoproteins whose glycan structures change due to hepatic diseases, providing novel markers specific to these conditions.

Career Highlights

Throughout his career, Toshihide Shikanai has worked with esteemed institutions such as the National Institute of Advanced Industrial Science and Technology and Nagoya City University. His research has significantly advanced the understanding of hepatic diseases and their detection.

Collaborations

Toshihide has collaborated with notable colleagues, including Hisashi Narimatsu and Jun Hirabayashi. Their combined expertise has contributed to the development of innovative solutions in the field of hepatic disease diagnostics.

Conclusion

Toshihide Shikanai's work in developing glycan markers represents a significant advancement in the detection of hepatic diseases. His contributions are vital for improving diagnostic methods and enhancing patient care in liver disease management.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…